h.nakamura
Submits third-party assay reports on material purchased directly. Based in Aalborg.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.01%
n=9
Suppliers covered
9
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042806 | Retatrutide | GGPeps | GGPE-2512-D2133 | PeptideMeter | 2026-Q2 | 99.24 | 3.50 | 105.4 | Supplier-supplied | 0 | PASS |
| AX-2026-042279 | Semaglutide | TFC | TFC-2602-H9925 | Medutest | 2026-Q1 | 99.41 | 1.58 | 104.1 | Buyer-sourced | 0 | PASS |
| AX-2026-042948 | Semaglutide | MKM | MKM-2510-S3812 | PeptideMeter | 2026-Q1 | 98.37 | 5.63 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043560 | Liraglutide | SIG | SIG-2508-6459 | VendorInvestigate | 2026-Q1 | 98.48 | 4.85 | 98.8 | Laboratory-retained | 0 | PASS |
| AX-2025-021050 | Gonadorelin | BCH | BCH-2510-F4167 | VendorInvestigate | 2025-Q4 | 98.49 | 5.24 | 94.7 | Buyer-sourced | 0 | FAIL |
| AX-2025-019322 | Semaglutide | AMB | AMB-2503-S5891 | Janoshik | 2025-Q3 | 99.24 | 5.52 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019982 | Tirzepatide | HJ | HJ-2505-H6642 | Janoshik | 2025-Q2 | 98.53 | 4.99 | 91.7 | Buyer-sourced | 0 | PASS |
| AX-2024-004237 | GHRP-6 | QYB | QYB-2410-S4374 | Kestrel | 2024-Q4 | 99.93 | 6.98 | 91.8 | Buyer-sourced | 0 | PASS |
| AX-2024-004451 | Hexarelin | GSP | GSP-2311-C2917 | Nordanalyt | 2024-Q1 | 99.01 | 4.00 | 104.6 | Buyer-sourced | 0 | PASS |